ROIV ROIVANT SCIENCES LTD Business Restructuring 8-K Filing 2024 - Debt Renegotiation and Equity Commitment Roivant Sciences Ltd.'s subsidiary, Dermavant Sciences Ltd., has entered into agreements to renegotiate debt obligations and reduce potential cash payments by over $300 million, with Roivant committing to contribute $195 million in exchange for convertible preferred shares.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD